lucicebtide (ST101)

News alerts, weekly reports and conference planners

Company:

Sapience Therap

Drug class:

CEBPB antagonist

Related drugs:

‹

›

No biomarker	Glioblastoma	No biomarker	Glioblastoma	ST101 Sensitive: B - Late Trials ST101 Sensitive : B	ST101 Sensitive: B - Late Trials ST101 Sensitive : B
HR positive	Hormone Receptor Positive Breast Cancer	HR positive	Hormone Receptor Positive Breast Cancer	ST101 Sensitive: C2 – Inclusion Criteria ST101 Sensitive : C2	ST101 Sensitive: C2 – Inclusion Criteria ST101 Sensitive : C2

Associations
(2)